Amalgamated Bank Adaptive Biotechnologies Corp Transaction History

Amalgamated Bank

$13.6 Billion
Q3 2025

A detailed history of Amalgamated Bank transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Amalgamated Bank holds 3,992 shares of ADPT stock, worth $56,287. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,992

Previous 3,992 -0.0%

Holding current value

$56,287

Previous $46,000 28.26%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$6.07 - $8.66 $1,214 - $1,732	200 Added 5.27%	3,992 $30,000
Q1 2024 Apr 23, 2024	SELL	$2.88 - $4.8 $30,539 - $50,899	-10,604 Reduced 73.66%	3,792 $12,000
Q4 2023 Feb 06, 2024	SELL	$3.46 - $5.33 $3,906 - $6,017	-1,129 Reduced 7.27%	14,396 $71,000
Q2 2023 Aug 11, 2023	BUY	$6.19 - $8.78 $24,035 - $34,092	3,883 Added 33.35%	15,525 $104,000
Q1 2023 May 02, 2023	SELL	$7.8 - $10.11 $22,549 - $29,228	-2,891 Reduced 19.89%	11,642 $103,000
Q4 2022 Feb 10, 2023	BUY	$6.26 - $9.34 $2,003 - $2,988	320 Added 2.25%	14,533 $111,000
Q3 2022 Nov 09, 2022	BUY	$6.5 - $12.67 $91 - $177	14 Added 0.1%	14,213 $101,000
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $68,569 - $157,817	-10,714 Reduced 43.01%	14,199 $115,000
Q1 2022 Jun 30, 2022	BUY	$10.12 - $28.9 $23,124 - $66,036	2,285 Added 10.1%	24,913 $346,000
Q4 2021 Feb 15, 2022	BUY	$25.17 - $36.85 $74,100 - $108,486	2,944 Added 14.96%	22,628 $635,000
Q3 2021 Oct 29, 2021	SELL	$30.02 - $39.87 $36,384 - $48,322	-1,212 Reduced 5.8%	19,684 $669,000
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $216,389 - $299,466	6,716 Added 47.36%	20,896 $854,000
Q1 2021 May 13, 2021	SELL	$37.26 - $67.74 $46,127 - $83,862	-1,238 Reduced 8.03%	14,180 $571,000
Q4 2020 Feb 12, 2021	SELL	$45.01 - $65.47 $270 - $392	-6 Reduced 0.04%	15,418 $911,000
Q3 2020 Oct 30, 2020	BUY	$35.79 - $48.81 $24,015 - $32,751	671 Added 4.55%	15,424 $750,000
Q2 2020 Aug 10, 2020	SELL	$24.95 - $48.38 $38,872 - $75,376	-1,558 Reduced 9.55%	14,753 $714,000
Q1 2020 May 13, 2020	BUY	$16.96 - $34.16 $276,634 - $557,183	16,311 New	16,311 $453,000

Others Institutions Holding ADPT

# of Institutions

290

Shares Held

147M

Call Options Held

23.5K

Put Options Held

33.3K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $2.01B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Adaptive Biotechnologies Corp Transaction History